Skip to Main Content

Paper Details

Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2.
Nature
86
2022
COVID-19, Pyrimidine, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 virus, flu-like symptoms, human, human respiratory cells, molnupiravir, nucleoside, nucleoside triphosphates, people, pyrimidine, remdesivir
Author NameAffiliation
Stuart WestonCenter for Pathogen Research, University of Maryland School of Medicine
Holly HammondCenter for Pathogen Research, University of Maryland School of Medicine
Matthew B FriemanCenter for Pathogen Research, University of Maryland School of Medicine
Matthew B FriemanCenter for Pathogen Research, University of Maryland School of Medicine
Sara CherryUniversity of Pennsylvania
Sara CherryUniversity of Pennsylvania
Sara CherryUniversity of Pennsylvania
  • 1 - 7

Datasets

Release 1.2